Bactiguard Holding ABCHIX:BACTBS 52 Altman Z-Score is 0.31 as of Jun. 27, 2026, which is 90% below its 10-year median of 3.22. GuruFocus rates CHIX:BACTBS with a GF Score™ of 52/100 and a GF Value™ of kr264.39. The stock has 3 warning signs investors should review. Among 809 Medical Devices & Instruments companies, Bactiguard Holding AB ranks worse than 77.87% on this metric.
The Altman Z-Score is a model designed to predict the likelihood of a company going bankrupt within the next two years. Created by American finance professor Edward Altman in 1968, the model is specifically designed for publicly traded manufacturing companies with assets greater than $1 million.
Warning Sign:
Altman Z-score of 0.36 is in distress zone. This implies bankruptcy possibility in the next two years.
Bactiguard Holding AB has a Altman Z-Score of 0.31, indicating it is in Distress Zones. This implies bankrupcy possibility in the next two years.
The zones of discrimination were as such:
When Altman Z-Score <= 1.8, it is in Distress Zones.
When Altman Z-Score >= 3, it is in Safe Zones.
When Altman Z-Score is between 1.8 and 3, it is in Grey Zones.
The historical rank and industry rank for Bactiguard Holding AB's Altman Z-Score or its related term are showing as below:
CHIX:BACTBs'
s Altman Z-Score Range Over the Past 10 Years
Min: 0.35 Med: 3.22 Max: 11.64
Current: 0.36
During the past 13 years, Bactiguard Holding AB's highest Altman Z-Score was 11.64. The lowest was 0.35. And the median was 3.22.
Bactiguard Holding AB (CHIX:BACTBs) Altman Z-Score Explanation
X1: The Working Capital/Total Assets (WC/TA) ratio is a measure of the net liquid assets of the firm relative to the total capitalization. Working capital is defined as the difference between current assets and current liabilities. Ordinarily, a firm experiencing consistent operating losses will have shrinking current assets in relation to total assets. Altman found this one proved to be the most valuable liquidity ratio comparing with the current ratio and the quick ratio. This is however the least significant of the five factors.
X2: Retained Earnings/Total Assets: the RE/TA ratio measures the leverage of a firm. Retained earnings is the account which reports the total amount of reinvested earnings and/or losses of a firm over its entire life. Those firms with high RE, relative to TA, have financed their assets through retention of profits and have not utilized as much debt.
X3, Earnings Before Interest and Taxes/Total Assets (EBIT/TA): This ratio is a measure of the true productivity of the firm's assets, independent of any tax or leverage factors. Since a firm's ultimate existence is based on the earning power of its assets, this ratio appears to be particularly appropriate for studies dealing with corporate failure. This ratio continually outperforms other profitability measures, including cash flow.
X4, Market Value of Equity/Book Value of Total Liabilities (MVE/TL): The measure shows how much the firm's assets can decline in value (measured by market value of equity plus debt) before the liabilities exceed the assets and the firm becomes insolvent.
X5, Revenue/Total Assets (S/TA): The capital-turnover ratio is a standard financial ratio illustrating the sales generating ability of the firm's assets.
Altman Z-Score does not apply to financial companies.
Bactiguard Holding AB Altman Z-Score Related Terms
Bactiguard Holding AB Altman Z-Score Historical Data
* Premium members only.
The historical data trend for Bactiguard Holding AB's Altman Z-Score can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CHIX:BACTBS vs ABT, SYK, MDT: Altman Z-Score Comparison
For the Medical Devices subindustry, Bactiguard Holding AB's Altman Z-Score, along with its competitors' market caps and Altman Z-Score data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bactiguard Holding AB Altman Z-Score vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Bactiguard Holding AB's Altman Z-Score distribution charts can be found below:
* The bar in red indicates where Bactiguard Holding AB's Altman Z-Score falls into.
Altman Z-Score model is an accurate forecaster of failure up to two years prior to distress. It can be considered the assessment of the distress of industrial corporations.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency. GuruFocus does not calculate Altman Z-Score when X4 or X5 value is 0.
Bactiguard Holding AB (CHIX:BACTBS) has a Altman Z-Score of 0.31 as of Jun. 27, 2026. The Altman Z-score measures a company's bankruptcy risk. View historical data on Bactiguard Holding AB and its competitors. This is 90% below median its historical median of 3.22. Over the past decade, Bactiguard Holding AB's Altman Z-Score has ranged from 0.35 to 11.64. According to the industry distribution chart, Bactiguard Holding AB ranks #630 out of 809 companies in the Medical Devices & Instruments industry, placing it in the top 77.9%.
Is Bactiguard Holding AB's Altman Z-Score too high?
Bactiguard Holding AB's current Altman Z-Score of 0.31 is 90% below median its 10-year median of 3.22. Over the past 10 years, this metric has ranged from a low of 0.35 to a high of 11.64. The Medical Devices & Instruments industry median Altman Z-Score is 2.92. Bactiguard Holding AB's value of 0.31 is 89.4% below this industry median. Based on the distribution chart, Bactiguard Holding AB ranks #630 out of 809 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Bactiguard Holding AB has a GF Score™ of 52/100, reflecting its overall financial health beyond just this single metric.
How does Bactiguard Holding AB's Altman Z-Score compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Bactiguard Holding AB ranks #630 out of 809 companies for Altman Z-Score. This places Bactiguard Holding AB in the lower half of its industry. The industry median Altman Z-Score is 2.92. Bactiguard Holding AB's value of 0.31 is 89.4% below this benchmark. Historically, Bactiguard Holding AB's own Altman Z-Score has ranged from 0.35 to 11.64 over the past decade. While the company's 10-year median is 3.22 vs. the industry median of 2.92, Bactiguard Holding AB has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Altman Z-Score for a Medical Devices & Instruments company?
The median Altman Z-Score among Medical Devices & Instruments companies is 2.92, based on 809 companies in the industry. Companies in the top quartile (top 25%) have a Altman Z-Score significantly above this median, while those in the bottom quartile fall well below. However, Altman Z-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Bactiguard Holding AB's current Altman Z-Score of 0.31 is 89.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Altman Z-Score mean?
A high Altman Z-Score can signal that a stock is expensive relative to its fundamentals. The Altman Z-score measures a company's bankruptcy risk. View historical data on Bactiguard Holding AB and its competitors. For the Medical Devices & Instruments industry, the median Altman Z-Score is 2.92 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bactiguard Holding AB's current Altman Z-Score is 0.31, which is 90% below median its own 10-year median of 3.22. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bactiguard Holding AB stock overvalued right now?
Bactiguard Holding AB (CHIX:BACTBS) has a current Altman Z-Score of 0.31. The stock's GF Value™ is kr264.39, compared to a current price of kr128.60 — trading 51.4% below its estimated fair value. The current Altman Z-Score is 0.31, which is 90% below median its 10-year median of 3.22 and 89.4% below the Medical Devices & Instruments industry median of 2.92. Bactiguard Holding AB's overall GF Score™ is 52/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Altman Z-Score calculated?
Altman Z-Score is calculated from a company's financial statements. For Bactiguard Holding AB (CHIX:BACTBS), the current Altman Z-Score is 0.31 as of Jun. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Bactiguard Holding AB (CHIX:BACTBS) Overvalued in 2026?
Based on GuruFocus' analysis, Bactiguard Holding AB stock appears to be undervalued.
The current stock price of kr128.60 is trading 51.4% below its estimated GF Value™ of kr264.39.
Key valuation signals for CHIX:BACTBS:
Altman Z-Score: 0.31 (90% below median its 10-year median of 3.22)
GF Value™: kr264.39 vs. price of kr128.60 (51.4% below fair value)
Industry Position: 89.4% below the Medical Devices & Instruments median (#630 of 809)
No single metric tells the full story. See the CHIX:BACTBS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Bactiguard Holding AB is a medical device company. It is engaged in a MedTech company developing safe and biocompatible technology to prevent medical device-related infections. The technology is based on an ultra-thin noble metal coating that prevents bacterial adhesion and biofilm formation on medical devices. The company focuses on five strategic therapeutic areas wherein infection rates create high medical needs for infection prevention. These areas include Orthopedics, Cardiology, Neurology, Urology, and Vascular Access. Geographically, the company operates in the USA, Malaysia, China, Saudi Arabia, Bangladesh, Sweden, the Czech Republic, and Other countries. The majority of its revenue is generated from the USA region.
52GF Score
Get the complete analysis for CHIX:BACTBS
Altman Z-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CHIX:BACTBS has been successfully added to your 
